An improved imaging agent for malignant melanoma, based on [Nle4,D-Phe7]alpha-melanocyte stimulating hormone. [electronic resource]
- Nuclear medicine communications Oct 1995
- 860-6 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't